Richard W. Martin, Ph.D.

Associate

Richard W. Martin, Ph.D., is a registered patent attorney focusing on prosecution and counseling in the life sciences sector. Rich concentrates his practice on biotechnology and pharmaceutical patent matters with an emphasis on intellectual property portfolio management, patent preparation and prosecution, pre-litigation counseling, and opinions and strategic advice relating to complex patentability, patent validity, infringement, and freedom-to-operate issues. Rich also has experience representing universities, emerging biotechnology companies, and large pharmaceutical concerns in disputes before the US Patent and Trademark Office, US District Courts, and in arbitration proceedings. His practice encompasses diverse technical subject matter, including biologic and small molecule pharmaceuticals, stem cells, transgenic animal and plant technology, genomics, metabolomics, microbiomics, and diagnostic methods.

Extended Profile

Rich received his Ph.D. from the University of Chicago in the department of molecular genetics and cell biology. His doctoral work focused on the role of the breast cancer susceptibility gene BRCA1 in maintaining genome integrity, particularly its involvement in DNA signaling and repair pathways.

Before joining Morgan Lewis, Rich practiced at a Chicago-based intellectual property boutique where he focused on life sciences patent matters. Prior to and during law school he served as a technical advisor with two prominent patent litigation practices.